Filing Details

Accession Number:
0001235802-17-000012
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-10 16:43:17
Reporting Period:
2017-01-09
Filing Date:
2017-01-10
Accepted Time:
2017-01-10 16:43:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1374128 Entellus Medical Inc ENTL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1306117 E Brian Farley 3600 Holly Lane North, Suite 40
Plymouth MN 55447
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2017-01-09 5,000 $19.12 449,423 No 4 S Direct
Common Stock, $0.001 Par Value Disposition 2017-01-10 4,842 $19.10 444,581 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.12, inclusive. The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.11, inclusive. The reporting person undertakes to provide to Entellus Medical, Inc., any security holder of Entellus Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.